Nurix Therapeutics, Inc. Quarterly Preferred Stock, Par or Stated Value Per Share in USD/shares from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD/shares
Description
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Summary
Nurix Therapeutics, Inc. quarterly Preferred Stock, Par or Stated Value Per Share history and growth rate from Q4 2019 to Q3 2024.
  • Nurix Therapeutics, Inc. Preferred Stock, Par or Stated Value Per Share for the quarter ending August 31, 2024 was 0 USD/shares, unchanged year-over-year.
Preferred Stock, Par or Stated Value Per Share, Quarterly (USD/shares)
Preferred Stock, Par or Stated Value Per Share, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $0 $0 0% Aug 31, 2024 10-Q 2024-10-11
Q2 2024 $0 $0 0% May 31, 2024 10-Q 2024-07-11
Q1 2024 $0 $0 0% Feb 29, 2024 10-Q 2024-04-10
Q4 2023 $0 $0 0% Nov 30, 2023 10-Q 2024-10-11
Q3 2023 $0 $0 0% Aug 31, 2023 10-Q 2023-10-12
Q2 2023 $0 $0 0% May 31, 2023 10-Q 2023-07-13
Q1 2023 $0 $0 0% Feb 28, 2023 10-Q 2023-04-13
Q4 2022 $0 $0 0% Nov 30, 2022 10-K 2024-02-15
Q3 2022 $0 $0 0% Aug 31, 2022 10-Q 2022-10-06
Q2 2022 $0 $0 0% May 31, 2022 10-Q 2022-07-07
Q1 2022 $0 $0 0% Feb 28, 2022 10-Q 2022-04-08
Q4 2021 $0 $0 0% Nov 30, 2021 10-K 2023-02-09
Q3 2021 $0 $0 0% Aug 31, 2021 10-Q 2021-10-14
Q2 2021 $0 May 31, 2021 10-Q 2021-07-13
Q1 2021 $0 Feb 28, 2021 10-Q 2021-04-13
Q4 2020 $0 $0 0% Nov 30, 2020 10-K 2022-01-28
Q3 2020 $0 Aug 31, 2020 10-Q 2020-10-14
Q4 2019 $0 Nov 30, 2019 10-K 2021-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.